A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac Angiography
The main purpose of this study is to compare the incidence of contrast induced nephrotoxicity following the administration of Isovue or Visipaque in patients with moderate to severe renal insufficiency undergoing cardiac angiography. Serum creatinine will be measured before and up to 48-72 hours after the administration of the contrast agent to evaluate renal function.
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
|Official Title:||Visipaque and Isovue in Cardiac Angiography in Renally Impaired Patients|